Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancerMengmeng Lü, Qing Zhang, Zhen Li et al.|Pharmacological Research|2021Cited by 50
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCsXiaokang Zhang, Qing Zhang, Shishuo Sun et al.|Journal of Cancer Research and Clinical Oncology|2022Cited by 24
PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ fluxShishuo Sun, Qing Zhang, Heng Xu et al.|Cancer Letters|2023Cited by 23
DHA attenuates CAR-T cell efficacy through aggravating exhaustion and inducing apoptosisYifei Wang, Shishuo Sun, Yuxiao Zhao et al.|Biologia|2023Cited by 2
Lenvatinib Enhances T Cell Immunity and the Efficacy of Adoptive Chimeric Antigen Receptor-Modified T Cells by Decreasing Myeloid-Derived Suppressor Cells in CancerMengmeng Lü, Qing Zhang, Xiaokang Zhang et al.|SSRN Electronic Journal|2021Cited by 1